This industry-led declaration is a smokescreen that unfairly puts the onus on patients by only focusing on disposal and not their own production and supply chains as a pathway of pharmaceuticals entering the environment.
Identifying opportunities for further engagement on climate-related issues, including the specific issue of anaesthetic gases.
People need access to safe water - this includes assurances that their water is not contaminated with pharmaceutical residues and antimicrobial resistant microorganisms.
Our latest publication provides policy background leading up to historic adoption of the Minamata Convention and subsequent EU Mercury Regulation - which can be seen as a first step towards a full phase-out.
In our response to the European Commission public consultation, we presented a series of policy measures that would help reduce pharmaceutical pollution in the environment.